NeoManna
Antimicrobial Solutions For Animal Health
StartupNeoManna is a Tel Yosef-based startup in the Agriculture & Food Technologies sector, established in 2022. Antimicrobial Solutions For Animal Health. NeoManna was founded by Amir Barzilay. Key investors include AgChimedes Group. The company has 1-10 employees. Core technologies: Biologicals, Genes.
The company follows a B2B business model. Product stage: Released.
- StageSeed
- ProductReleased
- ModelB2B
- Employees1-10
- HQTel Yosef
- Last RoundUndisclosed
- AgChimedes Group
Amir BarzilayCo-founder & CEO
What does NeoManna do?
NeoManna is focused on addressing the global challenges and pitfalls of Anti-Microbial Resistance (AMR). NeoManna specializes in developing, manufacturing and selling novel, natural anti-microbial and anti-inflammatory products that successfully combat the overuse of antibiotics in livestock, aquaculture, and companion animals. The company's innovative CAPEX-free model and groundbreaking R&D in Black Soldier Fly (BSF) originates bioactives, already provide high-volume, competitively priced modified BSF ingredients incorporated into both liquid animal nutrition and solid animal nutrition, thereby reducing production costs, improving EBITDA and safeguarding the global food value chain severely impacted by the combination of climate change and globalization withdrawal. NeoManna is an AgChimedes Group company.
Who founded NeoManna?
NeoManna was founded in 2022 by Amir Barzilay (Co-founder & CEO).
What sector is NeoManna in?
NeoManna operates in Climate Tech, Clean Industry Tech , Sustainable Materials & Circularity, Food & Land Use, Sustainable Farming, Agriculture & Food Technologies, Ag Tech, Farm Equipment & Treatment, with core technologies in Biologicals, Genes. Target customers: Agriculture & Food, Livestock, Insects, Marine Life, Processed Foods, Crops, Healthcare & Life Sciences, Life Sciences, Cosmetics.
Where is NeoManna located?
NeoManna is based in Tel Yosef, Israel.